Accelerate Diagnostics (AXDX) Misses Q1 EPS by 2c

Accelerate Diagnostics (NASDAQ: AXDX) reported Q1 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $2.81 million versus the consensus estimate of $3.35 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Royal Unibrew reports higher interim first-half profit as margins improve
• Aon names interim CFO as Edmund Reese exits the firm